Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2000
06/15/2000CA2354190A1 Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
06/15/2000CA2354188A1 Cancer cell vaccine
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2354028A1 Neisseria meningitidis basb041 polypeptides and encoding polynucleotides and uses thereof
06/15/2000CA2353773A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000CA2353620A1 Methods and formulations for reducing circulating antibodies
06/15/2000CA2352608A1 Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus
06/15/2000CA2351890A1 Method and composition for preserving viruses
06/15/2000CA2351452A1 Methods and compositions useful for targeting activated vitronectin receptor .alpha.v.beta.3
06/15/2000CA2349404A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/14/2000EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
06/14/2000EP1007720A1 Dendritic cell hybrids
06/14/2000EP1007700A1 Immunological detection of prions
06/14/2000EP1007696A1 Il-13 receptor specific chimeric proteins and uses thereof
06/14/2000EP1007688A2 Desaturase antigen of mycobacterium tuberculosis
06/14/2000EP1007687A1 Fiv vaccine
06/14/2000EP1007686A1 Tuberculosis vaccine
06/14/2000EP1007685A2 Surface exposed proteins from chlamydia pneumoniae
06/14/2000EP1007678A1 Kringle1
06/14/2000EP1007677A2 Protease-related protein
06/14/2000EP1007667A1 Nucleic acids encoding sperm antigens and reprosa-i polypeptides
06/14/2000EP1007666A1 Neurturin receptor
06/14/2000EP1007650A1 Pca3, pca3 genes, and methods of use
06/14/2000EP1007645A1 Human serum inducible kinase (snk)
06/14/2000EP1007625A1 Immunity enhancing lactic acid bacteria
06/14/2000EP1007569A1 STIMULATION OF AN IMMUNE RESPONSE WITH ANTIBODIES LABELED WITH THE $g(a)-GALACTOSYL EPITOPE
06/14/2000EP1007567A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007551A2 Vaccine against hpv
06/14/2000EP1007550A2 COMPOUNDS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF $i(EHRLICHIA) INFECTION
06/14/2000EP1007548A1 Tsetse thrombin inhibitor
06/14/2000EP1007546A1 Molecular mimetics of meningococcal b epitopes
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007537A1 Receptor protein designated 2f1
06/14/2000EP1007535A1 Methods and compositions for diagnosis and treatment of breast cancer
06/14/2000EP1007095A2 Chimeric toxins for targeted therapy
06/14/2000EP1007092A1 A process for inhibiting complement activation via the alternative pathway
06/14/2000EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/14/2000EP1007089A1 Anticoagulant agents useful in treatment of thrombosis
06/14/2000EP1007088A1 Recombinant porcine adenovirus vector
06/14/2000EP1007087A1 INDUCTION OF CTLs SPECIFIC FOR NATURAL ANTIGENS BY CROSS-PRIMING IMMUNIZATION
06/14/2000EP1007084A1 Immunogenic lhrh compositions and methods relating thereto
06/14/2000EP1007081A1 Universal t-cell epitopes for anti-malarial vaccines
06/14/2000EP1007079A1 Identification of broadly reactive dr restricted epitopes
06/14/2000EP1007075A1 Structurally modified peptides resistant to peptidase degradation
06/14/2000EP1007071A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
06/14/2000EP1007069A1 Novel coding sequences
06/14/2000EP1007000A2 Stable particle in liquid formulations
06/14/2000EP1006999A2 Use of submicron oil-in-water emulsions with dna vaccines
06/14/2000EP1006796A1 Compositions and methods for administering borrelia dna
06/14/2000EP1006782A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
06/14/2000EP0754193B1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
06/14/2000EP0677057B1 Biopolymer synthesis utilizing surface activated, organic polymers
06/14/2000CN1256696A Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it
06/14/2000CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
06/14/2000CN1256626A Stable particle in liquid formulations
06/14/2000CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line
06/14/2000CN1256151A Preparation of multiepitope epitope vaccine
06/14/2000CN1256150A Preparation of epitope vaccine with single monoepitope or multiple monoepitope duplication
06/14/2000CN1256149A Preparation of dissociation-resisting epitope vaccine
06/13/2000US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents
06/13/2000US6075119 Particles useful in the prevention and treatment of staphylococcal or streptococcal infection
06/13/2000US6075008 Method for promoting cell proliferation and growth
06/13/2000US6074873 Nucleic acids encoding NL-3
06/13/2000US6074872 Nucleic acid sequence coding a nervous system polypeptide; for inducing sleep in mammals and the treatment of sleep defects; for screening potential modulators of sleep
06/13/2000US6074866 Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines
06/13/2000US6074865 Recombinant viral nucleotide sequences which code envelope protein; for the development of a vaccine for treatment and prevention of viral infection
06/13/2000US6074852 Producing mannose-terminated protein by culturing host cell transformed with gene from e1 or e2 region, causing expression but inhibiting sialylation, isolating glycoprotein using mannose-binding protein
06/13/2000US6074846 Hepatitis C virus asialoglycoproteins
06/13/2000US6074841 Don-1 gene and polypeptides and uses therefor
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074816 Oligonucleotides which hybridize to genome of non a and non b hepatitis virus; for probes and primers
06/13/2000US6074689 Colonic delivery of protein or peptide compositions
06/13/2000US6074673 Slow-release, self-absorbing, drug delivery system
06/13/2000US6074651 Vaccine based on TGEV for protection of canines against canine coronavirus
06/13/2000US6074650 Membrane anchor/active compound conjugate, its preparation and its uses
06/13/2000US6074649 Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
06/13/2000US6074645 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
06/13/2000US6074644 Cytotoxic activity
06/13/2000US6074643 Site-directed chemotherapy of metastases
06/13/2000US6074642 Reduce cell lysing ability of biological complement present in blood
06/13/2000US6074637 Modifying cells by transfection with dna
06/13/2000CA2118309C Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
06/13/2000CA2077537C Therapeutically useful peptides and peptide fragments
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/13/2000CA1341021C Hepatitis surface antigen particle vaccine
06/09/2000CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method
06/09/2000CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032786A1 gp120 MUTANTS AND BIOLOGICAL APPLICATIONS
06/08/2000WO2000032784A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032776A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032768A1 Polypeptides capable of interacting with the human topoisomerase iii alpha
06/08/2000WO2000032755A1 Stable, attenuated rabies virus mutants and live vaccines thereof
06/08/2000WO2000032753A1 Heat inactivated retrovirus preparations
06/08/2000WO2000032745A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/08/2000WO2000032634A1 Humanized antibodies to gamma-interferon
06/08/2000WO2000032632A2 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
06/08/2000WO2000032626A1 Methods of using epitope peptides of human pathogens
1 ... 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 ... 1823